IL157389A0 - A pharmaceutical formulation comprising bicalutamide and an enteric polymer and use thereof as a medicament - Google Patents
A pharmaceutical formulation comprising bicalutamide and an enteric polymer and use thereof as a medicamentInfo
- Publication number
- IL157389A0 IL157389A0 IL15738902A IL15738902A IL157389A0 IL 157389 A0 IL157389 A0 IL 157389A0 IL 15738902 A IL15738902 A IL 15738902A IL 15738902 A IL15738902 A IL 15738902A IL 157389 A0 IL157389 A0 IL 157389A0
- Authority
- IL
- Israel
- Prior art keywords
- bicalutamide
- medicament
- pharmaceutical formulation
- enteric polymer
- enteric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0104749A GB2372444A (en) | 2001-02-27 | 2001-02-27 | A pharmaceutical formulation comprising bicalutamide and a hydroxypropylmethylcellulose polymer |
SE0102572A SE0102572D0 (sv) | 2001-07-19 | 2001-07-19 | Pharmaceutical formulation |
PCT/GB2002/000766 WO2002067893A2 (en) | 2001-02-27 | 2002-02-22 | Pharmaceutical formulation comprising bicalutamide |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157389A0 true IL157389A0 (en) | 2004-05-12 |
Family
ID=26245766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15738902A IL157389A0 (en) | 2001-02-27 | 2002-02-22 | A pharmaceutical formulation comprising bicalutamide and an enteric polymer and use thereof as a medicament |
Country Status (22)
Country | Link |
---|---|
US (1) | US20040067257A1 (xx) |
EP (1) | EP1368001B1 (xx) |
JP (2) | JP3548566B2 (xx) |
KR (1) | KR20030077042A (xx) |
CN (1) | CN1503662A (xx) |
AR (1) | AR032912A1 (xx) |
AT (1) | ATE307571T1 (xx) |
CA (1) | CA2439366A1 (xx) |
CZ (1) | CZ20032225A3 (xx) |
DE (1) | DE60206889T2 (xx) |
EE (1) | EE200300416A (xx) |
HU (1) | HUP0302847A3 (xx) |
IL (1) | IL157389A0 (xx) |
IS (1) | IS6915A (xx) |
MX (1) | MXPA03007641A (xx) |
NO (1) | NO20033785L (xx) |
NZ (1) | NZ527532A (xx) |
PL (1) | PL365746A1 (xx) |
RU (1) | RU2003128971A (xx) |
SK (1) | SK10722003A3 (xx) |
UY (1) | UY27186A1 (xx) |
WO (1) | WO2002067893A2 (xx) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103424D0 (sv) * | 2001-10-15 | 2001-10-15 | Astrazeneca Ab | Pharmaceutical formulation |
SE0103838D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Pharmaceutical formulation & product |
TWI355276B (en) * | 2003-01-14 | 2012-01-01 | Akira Tsuji | Gastrointestinal absorption enhancer mediated by p |
US20050008691A1 (en) * | 2003-05-14 | 2005-01-13 | Arturo Siles Ortega | Bicalutamide compositions |
JP4982084B2 (ja) * | 2004-02-09 | 2012-07-25 | 株式会社サンギ | 抗腫瘍剤 |
KR100539706B1 (ko) * | 2005-01-25 | 2005-12-28 | 지엘팜텍 주식회사 | 타크로리무스 및 장용성 고분자를 함유하는 고체분산체 |
JP2008531531A (ja) * | 2005-02-23 | 2008-08-14 | アストラゼネカ アクチボラグ | 方法 |
EP1872798B1 (en) * | 2005-04-06 | 2013-06-05 | Kabushiki Kaisha Sangi | Intestinal absorptive anti-tumor agent |
US7785629B2 (en) * | 2005-06-21 | 2010-08-31 | Helm Ag | Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof |
JP5052051B2 (ja) * | 2006-06-16 | 2012-10-17 | トーアエイヨー株式会社 | 腸溶性顆粒剤及びその製造方法 |
US20080045600A1 (en) * | 2006-08-17 | 2008-02-21 | Gawande Rahul S | Bicalutamide compositions |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
MX2010000617A (es) | 2007-07-17 | 2010-05-17 | Plexxikon Inc | Compuestos y metodos para modulacion de cinasa, e indicaciones de estos. |
WO2009038112A1 (ja) | 2007-09-21 | 2009-03-26 | Shionogi & Co., Ltd. | Npyy5受容体拮抗剤を含有する固形製剤 |
JP5204452B2 (ja) * | 2007-10-02 | 2013-06-05 | 日医工株式会社 | ビカルタミド含有製剤 |
JP2011503048A (ja) * | 2007-11-08 | 2011-01-27 | グラクソ グループ リミテッド | 医薬製剤 |
NZ594398A (en) | 2009-04-03 | 2014-03-28 | Plexxikon Inc | Propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrol [2, 3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl} -amide compositions and uses thereof |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
CN101987086B (zh) * | 2009-08-03 | 2012-07-18 | 北京化工大学 | 一种超细比卡鲁胺口服片剂及其制备方法 |
KR20120102669A (ko) | 2009-11-06 | 2012-09-18 | 플렉시콘, 인코퍼레이티드 | 키나제 조정을 위한 화합물 및 방법, 및 이를 위한 적응증 |
AU2010332797B2 (en) | 2009-12-18 | 2015-05-28 | Catalent Pharma Solutions Gmbh | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
CN102525876B (zh) * | 2010-12-15 | 2014-03-12 | 西安力邦医药科技有限责任公司 | 阿司匹林固体分散体、其制备方法、药物组合物和用途 |
CN102552103B (zh) * | 2010-12-20 | 2013-11-20 | 西安力邦医药科技有限责任公司 | 拉米夫定固体分散体、其制备方法、药物组合物和用途 |
US9624213B2 (en) | 2011-02-07 | 2017-04-18 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
TWI673051B (zh) | 2012-09-11 | 2019-10-01 | 美商梅維森***療法有限責任公司 | 恩雜魯它脈(enzalutamide)之調和物 |
SG11201700849XA (en) * | 2014-08-07 | 2017-03-30 | Pharmacyclics Llc | Novel formulations of a bruton's tyrosine kinase inhibitor |
ES2883187T3 (es) | 2014-12-05 | 2021-12-07 | Aragon Pharmaceuticals Inc | Composiciones anticancerosas |
CN109674752B (zh) * | 2016-12-15 | 2022-10-11 | 华领医药技术(上海)有限公司 | 葡萄糖激酶激活剂的口服制剂及其制备方法 |
MX2021012354A (es) | 2019-04-11 | 2021-10-22 | Scherer Technologies Llc R P | Formulación para suministro oral de proteínas, péptidos y moléculas pequeñas con poca permeabilidad. |
US11173291B2 (en) * | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100172B1 (en) * | 1982-07-23 | 1987-08-12 | Imperial Chemical Industries Plc | Amide derivatives |
DK0580860T4 (da) * | 1991-04-16 | 2005-03-21 | Nippon Shinyaku Co Ltd | Fremgangsmåde til fremstilling af en fast dispersion |
WO1995019770A1 (en) * | 1994-01-21 | 1995-07-27 | Sepracor, Inc. | Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
US20030059471A1 (en) * | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
DE60211139T2 (de) * | 2001-04-02 | 2007-03-01 | Astrazeneca Ab | Feste arzneizusammensetzung enthaltend 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide und pvp |
SE0103424D0 (sv) * | 2001-10-15 | 2001-10-15 | Astrazeneca Ab | Pharmaceutical formulation |
SE0103839D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Pharmaceutical formulation & product |
-
2002
- 2002-02-22 HU HU0302847A patent/HUP0302847A3/hu unknown
- 2002-02-22 KR KR10-2003-7011178A patent/KR20030077042A/ko not_active Application Discontinuation
- 2002-02-22 EE EEP200300416A patent/EE200300416A/xx unknown
- 2002-02-22 JP JP2002567261A patent/JP3548566B2/ja not_active Expired - Fee Related
- 2002-02-22 CZ CZ20032225A patent/CZ20032225A3/cs unknown
- 2002-02-22 NZ NZ527532A patent/NZ527532A/xx unknown
- 2002-02-22 PL PL02365746A patent/PL365746A1/xx not_active Application Discontinuation
- 2002-02-22 SK SK1072-2003A patent/SK10722003A3/sk unknown
- 2002-02-22 IL IL15738902A patent/IL157389A0/xx unknown
- 2002-02-22 WO PCT/GB2002/000766 patent/WO2002067893A2/en not_active Application Discontinuation
- 2002-02-22 RU RU2003128971/15A patent/RU2003128971A/ru not_active Application Discontinuation
- 2002-02-22 CA CA002439366A patent/CA2439366A1/en not_active Abandoned
- 2002-02-22 DE DE60206889T patent/DE60206889T2/de not_active Expired - Fee Related
- 2002-02-22 MX MXPA03007641A patent/MXPA03007641A/es unknown
- 2002-02-22 CN CNA028087356A patent/CN1503662A/zh active Pending
- 2002-02-22 EP EP02712105A patent/EP1368001B1/en not_active Expired - Lifetime
- 2002-02-22 AT AT02712105T patent/ATE307571T1/de not_active IP Right Cessation
- 2002-02-22 US US10/468,276 patent/US20040067257A1/en not_active Abandoned
- 2002-02-26 UY UY27186A patent/UY27186A1/es not_active Application Discontinuation
- 2002-02-27 AR ARP020100712A patent/AR032912A1/es not_active Application Discontinuation
-
2003
- 2003-08-15 IS IS6915A patent/IS6915A/is unknown
- 2003-08-26 NO NO20033785A patent/NO20033785L/no not_active Application Discontinuation
-
2004
- 2004-02-18 JP JP2004041583A patent/JP2004143185A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1503662A (zh) | 2004-06-09 |
WO2002067893A2 (en) | 2002-09-06 |
EP1368001A2 (en) | 2003-12-10 |
CZ20032225A3 (cs) | 2003-11-12 |
AR032912A1 (es) | 2003-12-03 |
JP2004143185A (ja) | 2004-05-20 |
SK10722003A3 (sk) | 2004-02-03 |
HUP0302847A2 (hu) | 2003-12-29 |
RU2003128971A (ru) | 2005-03-10 |
NO20033785D0 (no) | 2003-08-26 |
EE200300416A (et) | 2003-12-15 |
DE60206889D1 (de) | 2005-12-01 |
CA2439366A1 (en) | 2002-09-06 |
MXPA03007641A (es) | 2003-12-04 |
HUP0302847A3 (en) | 2005-05-30 |
JP2004521918A (ja) | 2004-07-22 |
WO2002067893A3 (en) | 2003-01-16 |
DE60206889T2 (de) | 2006-07-27 |
NO20033785L (no) | 2003-10-24 |
KR20030077042A (ko) | 2003-09-29 |
NZ527532A (en) | 2004-12-24 |
US20040067257A1 (en) | 2004-04-08 |
EP1368001B1 (en) | 2005-10-26 |
PL365746A1 (en) | 2005-01-10 |
UY27186A1 (es) | 2002-09-30 |
ATE307571T1 (de) | 2005-11-15 |
JP3548566B2 (ja) | 2004-07-28 |
IS6915A (is) | 2003-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157389A0 (en) | A pharmaceutical formulation comprising bicalutamide and an enteric polymer and use thereof as a medicament | |
IL156716A0 (en) | Pharmaceutical formulation | |
AU2002309172A1 (en) | Pharmaceutical compositions containing polymer and drug assemblies | |
EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
GB0118689D0 (en) | Pharmaceutical formulation | |
PL370563A1 (en) | Deuterated substituted pyrazolylbenzylsulfonamides and medicaments comprising said compounds | |
PL366432A1 (en) | Pharmaceutical formulation | |
GB0108470D0 (en) | Pharmaceutical compositions and their use | |
GB0322868D0 (en) | A novel catalytic formulation and its preparation technical field | |
HUP0402318A3 (en) | Pharmaceutical composition comprising cyclosporin and use thereof | |
IL161902A0 (en) | Pharmaceutical formulation comprising bicalutamide | |
EP1462455A4 (en) | NOVEL PEPTIDES AND THEIR USES AS MEDICAMENTS | |
IL161306A0 (en) | Pharmaceutical formulation comprising (r)-bicalutamide | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
PT1849468E (pt) | Composição farmacêutica compreendendo roflumilaste levocetirizina | |
EP1379228A4 (en) | (Z) -STYRYLBENZYLSULPONES AND THEIR PHARMACEUTICAL APPLICATIONS | |
AU2002354070A1 (en) | Medical polymers and use thereof | |
HUP0304063A3 (en) | Medicinal compositions comprising diclofenac and ornoprostil | |
IL153176A (en) | Phenylpiperazines and pharmaceutical compositions comprising them | |
AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
GB0000482D0 (en) | Enteric coated pharmaceutical formulation | |
GB0104749D0 (en) | Pharmaceutical formulation | |
PL370709A1 (en) | Pharmaceutical formulation comprising cyclosporin and use thereof |